These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 19758639)

  • 21. Seasonal variations in urinary risk factors among patients with nephrolithiasis.
    Stuart RO 2nd ; Hill K; Poindexter J; Pak CY
    J Lithotr Stone Dis; 1991 Jan; 3(1):18-27. PubMed ID: 11536932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in metabolic urinary abnormalities in stone forming and nonstone forming patients with primary hyperparathyroidism.
    Sorensen MD; Duh QY; Grogan RH; Tran TC; Stoller ML
    Surgery; 2012 Mar; 151(3):477-83. PubMed ID: 21893327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Roux-en-Y gastric bypass is associated with early increased risk factors for development of calcium oxalate nephrolithiasis.
    Duffey BG; Pedro RN; Makhlouf A; Kriedberg C; Stessman M; Hinck B; Ikramuddin S; Kellogg T; Slusarek B; Monga M
    J Am Coll Surg; 2008 Jun; 206(6):1145-53. PubMed ID: 18501812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of dietary changes on urinary oxalate excretion and calcium oxalate supersaturation in patients with hyperoxaluric stone formation.
    Penniston KL; Nakada SY
    Urology; 2009 Mar; 73(3):484-9. PubMed ID: 19118878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between serum vitamin D and 24-hour urine calcium in patients with nephrolithiasis.
    Eisner BH; Thavaseelan S; Sheth S; Haleblian G; Pareek G
    Urology; 2012 Nov; 80(5):1007-10. PubMed ID: 22698470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. National multi-institutional cooperative on urolithiasis in children: Age is a significant predictor of urine abnormalities.
    Cambareri GM; Kovacevic L; Bayne AP; Giel D; Corbett S; Schurtz E; Sukhu T; Chiang G
    J Pediatr Urol; 2015 Aug; 11(4):218-23. PubMed ID: 26119451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lithogenic risk factors in the morbidly obese population.
    Duffey BG; Pedro RN; Kriedberg C; Weiland D; Melquist J; Ikramuddin S; Kellogg T; Makhlouf AA; Monga M
    J Urol; 2008 Apr; 179(4):1401-6. PubMed ID: 18289566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in 24-h urine composition between nephrolithiasis patients with and without diabetes mellitus.
    Hartman C; Friedlander JI; Moreira DM; Elsamra SE; Smith AD; Okeke Z
    BJU Int; 2015 Apr; 115(4):619-24. PubMed ID: 24823472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR
    J Am Soc Nephrol; 2005 Feb; 16(2):417-24. PubMed ID: 15647340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adequacy of a single 24-hour urine collection for metabolic evaluation of recurrent nephrolithiasis.
    Castle SM; Cooperberg MR; Sadetsky N; Eisner BH; Stoller ML
    J Urol; 2010 Aug; 184(2):579-83. PubMed ID: 20639021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stone forming risk factors in patients with type Ia glycogen storage disease.
    Scales CD; Chandrashekar AS; Robinson MR; Cantor DA; Sullivan J; Haleblian GE; Leitao VA; Sur RL; Borawski KM; Koeberl D; Kishnani PS; Preminger GM
    J Urol; 2010 Mar; 183(3):1022-5. PubMed ID: 20092831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of semi-empirical and computer derived methods for estimating urinary saturation of calcium oxalate.
    Pak CY; Maalouf NM; Rodgers K; Poindexter JR
    J Urol; 2009 Dec; 182(6):2951-6. PubMed ID: 19846163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic syndrome in obese adolescents is associated with risk for nephrolithiasis.
    Tiwari R; Campfield T; Wittcopp C; Braden G; Visintainer P; Reiter EO; Allen HF
    J Pediatr; 2012 Apr; 160(4):615-620.e2. PubMed ID: 22099686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lemonade therapy increases urinary citrate and urine volumes in patients with recurrent calcium oxalate stone formation.
    Penniston KL; Steele TH; Nakada SY
    Urology; 2007 Nov; 70(5):856-60. PubMed ID: 17919696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nephrolithiasis in identical twins: the impact of nature vs nurture.
    Haleblian GE; Cantor DA; Sur RL; Assimos DG; Preminger GM
    BJU Int; 2007 Sep; 100(3):621-3. PubMed ID: 17669145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of prevalent hypertension with 24-hour urinary excretion of calcium, citrate, and other factors.
    Taylor EN; Mount DB; Forman JP; Curhan GC
    Am J Kidney Dis; 2006 May; 47(5):780-9. PubMed ID: 16632016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age-related changes in 24-hour urine composition must be considered in the medical management of nephrolithiasis.
    Friedlander JI; Moreira DM; Hartman C; Elsamra SE; Smith AD; Okeke Z
    J Endourol; 2014 Jul; 28(7):871-6. PubMed ID: 24571654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dyslipidemia and kidney stone risk.
    Torricelli FC; De SK; Gebreselassie S; Li I; Sarkissian C; Monga M
    J Urol; 2014 Mar; 191(3):667-72. PubMed ID: 24055417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcium oxalate crystallization index (COCI): an alternative method for distinguishing nephrolithiasis patients from healthy individuals.
    Yang B; Dissayabutra T; Ungjaroenwathana W; Tosukhowong P; Srisa-Art M; Supaprom T; Insin N; Boonla C
    Ann Clin Lab Sci; 2014; 44(3):262-71. PubMed ID: 25117095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fetuin-A gene polymorphism in patients with calcium oxalate stone disease.
    Aksoy H; Aksoy Y; Ozturk N; Aydin HR; Yildirim AK; Akçay F
    Urology; 2010 Apr; 75(4):928-32. PubMed ID: 19931899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.